Peptide Treatment 2026: $68B Market Surge Driven by 23% CAGR in Anti-Aging & Metabolic Therapeutics
Published: July 9, 2026 19:18
Author: Carlos Peña
Abstract: The peptide treatment market is projected to surge to $68 billion by 2026, driven by a 23% CAGR in anti-aging and metabolic therapeutics. This analysis evaluates key brands (e.g., Semaglutide, BPC-157) against technical parameters, comparing stability, bioavailability, and regulatory certifications (FDA, GMP). Current industry trends highlight a shift toward personalized peptides, with logistics requiring cold-chain integrity. Selection criteria prioritize purity (>98%) and clinical validation, underscoring the sector’s robust growth amid stringent quality standards.